ABSTRACT
BACKGROUND & AIMS: Tristetraprolin (TTP) is a key post-transcriptional regulator of inflammatory and oncogenic transcripts. Accordingly, TTP was reported to act as a tumor suppressor in specific cancers. Herein, we investigated how TTP contributes to the development of liver inflammation and fibrosis, which are key drivers of hepatocarcinogenesis, as well as to the onset and progression of hepatocellular carcinoma (HCC). METHODS: TTP expression was investigated in mouse/human models of hepatic metabolic diseases and cancer. The role of TTP in nonalcoholic steatohepatitis and HCC development was further examined through in vivo/vitro approaches using liver-specific TTP knockout mice and a panel of hepatic cancer cells. RESULTS: Our data demonstrate that TTP loss in vivo strongly restrains development of hepatic steatosis and inflammation/fibrosis in mice fed a methionine/choline-deficient diet, as well as HCC development induced by the carcinogen diethylnitrosamine. In contrast, low TTP expression fostered migration and invasion capacities of in vitro transformed hepatic cancer cells likely by unleashing expression of key oncogenes previously associated with these cancerous features. Consistent with these data, TTP was significantly down-regulated in high-grade human HCC, a feature further correlating with poor clinical prognosis. Finally, we uncover hepatocyte nuclear factor 4 alpha and early growth response 1, two key transcription factors lost with hepatocyte dedifferentiation, as key regulators of TTP expression. CONCLUSIONS: Although TTP importantly contributes to hepatic inflammation and cancer initiation, its loss with hepatocyte dedifferentiation fosters cancer cells migration and invasion. Loss of TTP may represent a clinically relevant biomarker of high-grade HCC associated with poor prognosis.
Subject(s)
Carcinoma, Hepatocellular/genetics , Liver Cirrhosis/genetics , Liver Neoplasms/genetics , Tristetraprolin/metabolism , Animals , Carcinogenesis/genetics , Carcinogenesis/immunology , Carcinogenesis/pathology , Carcinoma, Hepatocellular/immunology , Carcinoma, Hepatocellular/mortality , Carcinoma, Hepatocellular/pathology , Cell Line, Tumor , Datasets as Topic , Diethylnitrosamine/administration & dosage , Diethylnitrosamine/toxicity , Down-Regulation , Female , Gene Expression Regulation, Neoplastic/immunology , Hepatocytes , Humans , Liver/immunology , Liver/pathology , Liver Cirrhosis/immunology , Liver Cirrhosis/pathology , Liver Neoplasms/immunology , Liver Neoplasms/mortality , Liver Neoplasms/pathology , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/immunology , Liver Neoplasms, Experimental/pathology , Male , Mice , Non-alcoholic Fatty Liver Disease , Primary Cell Culture , Prognosis , RNA-Seq , Survival Analysis , Tristetraprolin/geneticsABSTRACT
Nonalcoholic steatohepatitis is considered as a precancerous condition. However, hepatic carcinogenesis from NASH is poorly understood. This study aims to investigate the activation of pluripotent genes (c-Myc, Oct-4, KLF-4, and Nanog) and morphogenic gene (Gli-1) in hepatic progenitor cells from patient specimens and in an animal model to determine the possibility of normal stem/progenitor cells becoming the origin of NASH-HCC. In this study, expression of pluripotent and morphogenic genes in human NASH-HCC tissues was significantly upregulated compared to adjacent non-tumor liver tissues. After feeding high-fat/calorie diet plus high fructose/glucose in drinking water (HFC diet plus HF/G) for up to 12 months, mice developed obesity, insulin resistance, and steatohepatitis with significant necroptotic inflammation and fibrotic progression, as well as occurrence of hyperplastic nodules with dysplasia; and this model represents pathohistologically as a transition from NASH to NASH-HCC in a pre-carcinomatous stage. High expression of pluripotent and morphogenic genes was immunohistochemically visualized in the dysplasia areas of mouse liver, where there were many OV-6-positive cells, indicating proliferation of HOCs in NASH with fibrotic progression. Moreover, oncogenic transcription factors (c-Myc, KLF-4, and Nanog) were co-localized in these hepatic progenitor cells. In conclusion, pluripotent and morphogenic genes may contribute to the reprogramming of hepatic progenitor cells in driving these cells to be the origin of NASH-HCC in a steatotic and inflamed microenvironment.
Subject(s)
Carcinoma, Hepatocellular/metabolism , DNA-Binding Proteins/metabolism , Hepatocytes/metabolism , Liver Neoplasms, Experimental/metabolism , Non-alcoholic Fatty Liver Disease/metabolism , Transcription Factors/metabolism , Animals , Carcinoma, Hepatocellular/chemistry , Carcinoma, Hepatocellular/genetics , DNA-Binding Proteins/genetics , Diet, High-Fat , Glucose Intolerance/metabolism , Hepatocytes/chemistry , Humans , Insulin Resistance , Kruppel-Like Factor 4 , Kruppel-Like Transcription Factors , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/genetics , Male , Mice , Mice, Inbred C57BL , Nanog Homeobox Protein , Non-alcoholic Fatty Liver Disease/genetics , Obesity/metabolism , Octamer Transcription Factor-3 , Proto-Oncogene Proteins c-myc , Transcription Factors/geneticsABSTRACT
BACKGROUND: Functional disturbances of the endoplasmic reticulum (ER) lead to activation of the unfolded protein response (UPR), which is involved in the consecutive steps of carcinogenesis. In human hepatocellular carcinoma (HCC), the UPR is shown to be activated; however, little is known about the UPR kinetics and effects of UPR modulation in HCC. METHODS: We sequentially monitored the UPR over time in an orthotopic mouse model for HCC and explored the effects of UPR modulation on cell viability and proliferation in vitro and in the mouse model. RESULTS: The expression of ER-resident chaperones peaked during tumor initiation and increased further during tumor progression, predominantly within the nodules. A peak in Ire1 signaling was observed during tumor initiation. The Perk pathway was activated during tumor progression, and the proapoptotic target Chop was upregulated from week 5 and continued to rise, especially in the tumors. The Atf6 pathway was modestly activated only after tumor initiation. Consistent with the UPR activation, electron microscopy demonstrated ER expansion and reorganization in HCC cells in vivo. Strikingly, under ER stress or hypoxia, the Perk inhibitor and not the Ire1 inhibitor reduced cell viability and proliferation via escalating proteotoxic stress in vitro. Notably, the Perk inhibitor significantly decreased tumor burden in the mouse model. CONCLUSION: We provide the first evaluation of the UPR dynamics in a long-term cancer model and identified a small molecule inhibitor of Perk as a promising strategy for HCC therapy.
Subject(s)
Carcinoma, Hepatocellular/metabolism , Cell Transformation, Neoplastic/metabolism , Liver Neoplasms, Experimental/metabolism , Protein Kinase Inhibitors/pharmacology , Unfolded Protein Response , eIF-2 Kinase/metabolism , Activating Transcription Factor 6/genetics , Adaptation, Physiological/drug effects , Animals , Carcinoma, Hepatocellular/chemistry , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/ultrastructure , Cell Proliferation/drug effects , Cell Survival/drug effects , Endoplasmic Reticulum , Endoplasmic Reticulum Chaperone BiP , HSP40 Heat-Shock Proteins/genetics , Heat-Shock Proteins/genetics , Hep G2 Cells , Humans , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/ultrastructure , Male , Membrane Glycoproteins/genetics , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/genetics , Mice , Oxidative Stress , Phosphorylation/drug effects , Protein Kinase Inhibitors/therapeutic use , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , RNA, Messenger/analysis , Signal Transduction , Transcription Factor CHOP/analysis , Transcription Factor CHOP/genetics , Tunicamycin/pharmacology , Unfolded Protein Response/drug effects , eIF-2 Kinase/antagonists & inhibitorsABSTRACT
The therapeutic efficacy of systemic drug-delivery vehicles depends on their ability to evade the immune system, cross the biological barriers of the body and localize at target tissues. White blood cells of the immune system--known as leukocytes--possess all of these properties and exert their targeting ability through cellular membrane interactions. Here, we show that nanoporous silicon particles can successfully perform all these actions when they are coated with cellular membranes purified from leukocytes. These hybrid particles, called leukolike vectors, can avoid being cleared by the immune system. Furthermore, they can communicate with endothelial cells through receptor-ligand interactions, and transport and release a payload across an inflamed reconstructed endothelium. Moreover, leukolike vectors retained their functions when injected in vivo, showing enhanced circulation time and improved accumulation in a tumour.
Subject(s)
Biomimetics/methods , Leukocytes/chemistry , Membranes, Artificial , Models, Biological , Nanoparticles/chemistry , Animals , Biological Transport , Cell Adhesion , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Human Umbilical Vein Endothelial Cells , Humans , Leukocytes/metabolism , Liver/chemistry , Liver/metabolism , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/metabolism , Mice , Mice, Inbred C57BL , PhagocytosisABSTRACT
In this study of chemoprevention in the rat modified resistant hepatocyte model, preneoplastic cells were diminished by >60% with quercetin pretreatment compared with those rats treated with N-Diethylnitrosamine (DEN) to induce liver cancer. This decrease occurred associated with an abolished DEN-induced lipid peroxidation as well as activation of caspase 9 and increased caspase 3, as determined by increased expression of cleaved caspase 3 and 9, but not cleaved caspase 8 and increased fragmentation of Poly (ADP-ribose) polymerase (PARP) inducing apoptosis of presumed genetically injured cells, when quercetin was administered before the initiation agent.
Subject(s)
Apoptosis/drug effects , Liver Neoplasms, Experimental/pathology , Liver Neoplasms, Experimental/prevention & control , Precancerous Conditions/drug therapy , Quercetin/pharmacology , Animals , Anticarcinogenic Agents/pharmacology , Antineoplastic Agents/pharmacology , Carcinogenesis/drug effects , Caspases/metabolism , Chemoprevention/methods , Liver/chemistry , Liver/drug effects , Liver/pathology , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/metabolism , Male , Oxidative Stress/drug effects , Precancerous Conditions/chemistry , Precancerous Conditions/metabolism , Precancerous Conditions/pathology , Rats , Rats, Inbred F344ABSTRACT
For preoperative and intraoperative detection of tumor distribution, numerous multimodal contrast agents, such as magnetic nanoparticles (MNPs) with several examination indicators, are currently in development. However, complex materials, configuration, and cost are required for multimodal contrast agents, accompanied by a high possibility of toxicity and low popularity in clinics. Nevertheless, the magnetic labeling of MNPs using bioprobes should be feasible not only in preoperative magnetic resonance imaging (MRI), but also in intraoperative examination based on other magnetic properties. In this study, anti-alpha-fetoprotein (AFP)-mediated Fe(3)O(4) MNPs, injected into mice with liver tumors, were used to examine the characteristics of magnetic labeling. Using MRI and scanning superconducting-quantum-interference-device biosusceptometry (SSB), based on alternating current (AC) susceptibility, the magnetic labeling occurred significantly on the first day post-injection of anti-AFP magnetic fluid (MF), and then decreased over time. However, for both MF without antibodies and an anti-carcinoembryonic antigen MF, no magnetic labeling occured on the first day of their respective post-injection. The favorable agreement indicates that magnetic labeling possesses two magnetic characteristics: distortion of the imaging field and AC susceptibility. In addition, the results of the biopsy tests, anti-AFP staining, and Prussian blue staining show the same dynamics as those of magnetic methodologies and prove that bound MNPs on tumor tissue are rotatable by an AC magnetic field to express AC susceptibility. Therefore, with the simple configuration of antibody-mediated MNPs, magnetic labeling is also feasible for intraoperative examinations using SSB with high mobility and sensitivity.
Subject(s)
Antibodies/metabolism , Contrast Media/chemistry , Liver Neoplasms, Experimental/chemistry , Magnetite Nanoparticles/chemistry , alpha-Fetoproteins/metabolism , Animals , Antibodies/chemistry , Contrast Media/metabolism , Contrast Media/pharmacokinetics , Histocytochemistry , Liver/chemistry , Liver Neoplasms, Experimental/metabolism , Magnetic Fields , Magnetic Resonance Imaging/methods , Mice , Mice, Inbred BALB C , Molecular Imaging/methods , Particle SizeABSTRACT
In this study, we investigated the effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma (HCC). LCL161 showed differential effects on apoptosis in four HCC cell lines, and the endogenous level of Bcl-2 determined the sensitivity of HCC cells to LCL161. Cytotoxicity and apoptosis were observed in sensitive PLC5 and Hep3B cells that express lower levels of Bcl-2, but not in resistant Huh-7 and SK-Hep1 cells with higher Bcl-2 expression. Down regulation of Bcl-2 by small interference RNA overcame the resistance to LCL161 in Huh-7, and the apoptotic effect was rescued in Bcl-2-expressing Hep3B. To test the hypothesis that Bcl-2 determines the sensitivity of HCC cells to LCL161, we assayed the biological effect of SC-2001, a novel Bcl-2 inhibitor derived from obatoclax, in LCL161-resistant cell lines. Huh-7 cells co-treated with LCL161 and SC-2001 showed a significant dose-dependent apoptotic effect demonstrated by sub-G1 assay and cleavage of PARP. Furthermore, the combination index (CI) of LCL161 and SC-2001 showed a convincing synergism in resistant Huh-7. In addition, the combinational therapy showed significant growth inhibition in Huh-7-bearing xenograft tumors. Notably, down regulation of Bcl-2 was observed in a tumor sample treated with LCL161 and SC-2001. In conclusion, targeting Bcl-2 with SC-2001 overcomes drug resistance to LCL161 in HCC cells thus suggesting a new anti-IAP combinational therapy for HCC.
Subject(s)
Biomimetic Materials/pharmacology , Carcinoma, Hepatocellular/metabolism , Liver Neoplasms, Experimental/chemistry , Oligopeptides/metabolism , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , Thiazoles/therapeutic use , Animals , Antineoplastic Agents/pharmacology , Carcinoma, Hepatocellular/drug therapy , Down-Regulation/drug effects , Down-Regulation/physiology , HEK293 Cells , Humans , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/metabolism , Male , Mice , Mice, Nude , Oligopeptides/chemistry , Oligopeptides/physiology , Proto-Oncogene Proteins c-bcl-2/metabolism , Pyrroles/pharmacology , Thiazoles/chemistry , Thiazoles/pharmacology , Treatment Outcome , Xenograft Model Antitumor Assays/methodsABSTRACT
Because liver cancer is rarely suitable for surgery, transcatheter arterial chemoembolization (TACE) is used for palliative therapy. In this procedure, an emulsion of doxorubicin in iodized oil is injected directly into liver tumors through a catheter positioned within the artery supplying blood flow to the tumor. At present, there is limited understanding of factors affecting the delivery and dispersion of doxorubicin within treated tumors during TACE. This study addresses the development and application of an ultrahigh-pressure liquid chromatography-tandem mass spectrometry (UHPLC-MS-MS) method for rapid confirmation of drug delivery after TACE in a rabbit VX2 liver cancer model. Doxorubicin levels in liver tumors were measured using UHPLC-MS-MS and compared with computed tomography measured levels of iodized oil, a metric used clinically to indicate drug delivery. We found that tissue drug levels determined using UHPLC-MS-MS did not correlate with the regional iodized oil concentration (vehicle) within tumors following TACE, suggesting that chemotherapeutic drugs like doxorubicin spread throughout tumors, and that lack of iodized oil staining in portions of a tumor does not necessarily indicate inadequate therapy during TACE.
Subject(s)
Chemoembolization, Therapeutic/methods , Chromatography, High Pressure Liquid/methods , Doxorubicin/analysis , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/therapy , Tandem Mass Spectrometry/methods , Animals , Antibiotics, Antineoplastic/administration & dosage , Antibiotics, Antineoplastic/analysis , Antibiotics, Antineoplastic/pharmacokinetics , Chemoembolization, Therapeutic/instrumentation , Doxorubicin/administration & dosage , Doxorubicin/pharmacokinetics , Drug Delivery Systems , Emulsions/chemistry , Ethiodized Oil/pharmacokinetics , Liver Neoplasms, Experimental/metabolism , Liver Neoplasms, Experimental/pathology , Male , Rabbits , Tomography, X-Ray ComputedABSTRACT
BACKGROUND: Nanomaterials are considered to be the pre-eminent component of the rapidly advancing field of nanotechnology. However, developments in the biologically inspired synthesis of nanoparticles are still in their infancy and consequently attracting the attention of material scientists throughout the world. Keeping in mind the fact that microorganism-assisted synthesis of nanoparticles is a safe and economically viable prospect, in the current study we report Candida albicans-mediated biological synthesis of gold nanoparticles. METHODS AND RESULTS: Transmission electron microscopy, atomic force microscopy, and various spectrophotometric analyses were performed to characterize the gold nanoparticles. The morphology of the synthesized gold particles depended on the abundance of C. albicans cytosolic extract. Transmission electron microscopy, nanophox particle analysis, and atomic force microscopy revealed the size of spherical gold nanoparticles to be in the range of 20-40 nm and nonspherical gold particles were found to be 60-80 nm. We also evaluated the potential of biogenic gold nanoparticles to probe liver cancer cells by conjugating them with liver cancer cell surface-specific antibodies. The antibody-conjugated gold particles were found to bind specifically to the surface antigens of the cancer cells. CONCLUSION: The antibody-conjugated gold particles synthesized in this study could successfully differentiate normal cell populations from cancerous cells.
Subject(s)
Candida albicans/metabolism , Gold/metabolism , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/diagnosis , Metal Nanoparticles/chemistry , Animals , Antibodies/chemistry , Antibodies/metabolism , Biomimetics , Cell Survival/drug effects , Cytosol/chemistry , Female , Gold/chemistry , Gold/pharmacokinetics , Gold/toxicity , HeLa Cells , Humans , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred BALB C , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Neoplasm Proteins/immunology , Neoplasm Proteins/metabolism , Particle Size , SpectrophotometryABSTRACT
Since the CALUX (Chemically Activated LUciferase gene eXpression) bioassay is a fast and inexpensive tool for the throughput analysis of dioxin-like compounds in a large number of samples and requires only small sample volumes, the use of this technique in human biomonitoring programs provides a good alternative to GC-HRMS. In this study, a method for the separate analysis of PCDD/Fs and dioxin-like PCBs (dl-PCBs) in human serum with the new sensitive H1L7.5c1 mouse hepatoma cell line was optimized. Sample dilution factors of 5 and 2.4 were selected for routine analysis of respectively the PCDD/Fs and dl-PCBs. The validation studies showed that repeatability and within-lab reproducibility for the quality control (QC) standard were within the in-house criteria. A long-term within-lab reproducibility of 25% for the PCDD/F fraction and 41% for the dl-PCB fraction for the analysis of pooled serum samples, expressed as pg BEQ/g fat, was determined. CALUX recoveries of the spiked procedural blanks were within the acceptable in-house limits of 80-120% for both fractions and the LOQ was 30.3 pg BEQ/g fat for the PCDD/Fs and 14.5 pg BEQ/g fat for the dl-PCBs. The GC-HRMS recovery of a C13-spiked pooled serum sample was between 60 and 90% for all PCDD/F congeners and between 67 and 82% for the non-ortho PCBs. An adequate separation between both fractions was found. The CALUX/GC-HRMS ratio for a pooled serum sample was respectively 2.0 and 1.4 for the PCDD/Fs and the dl-PCBs, indicating the presence of additional AhR active compounds. As expected, a correlation was found between human serum samples analyzed with both the new H1L7.5c1 cell line and the more established H1L6.1c3 cell line. The geometric mean CALUX-BEQ values, reported for the adolescents of the second Flemish Environment and Health Study (FLEHS II) recruited in 2009-2010, were 108 (95% CI: 101-114) pg CALUX-BEQ/g fat for the PCDD/Fs and 32.1 (30.1-34.2) pg CALUX-BEQ/g fat for the dioxin-like PCBs.
Subject(s)
Benzofurans/analysis , Liver Neoplasms, Experimental/chemistry , Polychlorinated Biphenyls/analysis , Polychlorinated Dibenzodioxins/analogs & derivatives , Adolescent , Animals , Belgium , Benzofurans/blood , Cell Line, Tumor , Dibenzofurans, Polychlorinated , Dose-Response Relationship, Drug , Gas Chromatography-Mass Spectrometry , Humans , Limit of Detection , Liver Neoplasms, Experimental/pathology , Mice , Polychlorinated Biphenyls/blood , Polychlorinated Dibenzodioxins/analysis , Polychlorinated Dibenzodioxins/blood , Reproducibility of ResultsABSTRACT
In a previous study, to identify genes of importance for hepatocellular carcinogenesis, and especially for processes involved in malignant transformation, the authors investigated differences in gene expression between adenomas and carcinomas by DNA microarray. In the present study, the authors investigated AW434047, one of the sequences that was upregulated in carcinomas. The investigation led to the identification of a novel gene, which the authors named hepatocyte malignant transforming factor (HMTF), of unknown function whose expression was increased in hepatocellular carcinomas. Northern blot and in situ hybridization also demonstrated high levels of HMTF in rat hepatocellular carcinoma (HCC) cell lines, lymphocytes in the spleen, colon mucosal epithelia, spermatocytes, and granule cells of the hippocampus. Reduction of HMTF by RNA interference (RNAi) in N1 cells, an HCC cell line, caused suppression of cell proliferation, invasion, and migration. Suppression of proliferation appeared to be due to cell cycle arrest without increased apoptosis. Decreased HMTF expression resulted in down-regulation of STAT3, PCNA, and cyclin D1 and upregulation of p27. These results suggest that HMTF is a new marker for rat HCC and is involved in HCC cell proliferation and may also be linked to cell proliferation in the spleen, colon, brain, and testis.
Subject(s)
Biomarkers, Tumor/metabolism , Cell Transformation, Neoplastic/metabolism , Liver Neoplasms, Experimental/metabolism , Neoplasm Proteins/metabolism , Animals , Apoptosis , Biomarkers, Tumor/chemistry , Biomarkers, Tumor/genetics , Cell Growth Processes/physiology , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Gene Knockdown Techniques , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/pathology , Male , Neoplasm Proteins/chemistry , Neoplasm Proteins/genetics , Organ Specificity , RNA Interference , RNA, Small Interfering/pharmacology , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/drug effects , Signal Transduction/geneticsABSTRACT
There is a paucity of data regarding the safety of administering solid gold nanoparticles (AuNPs) in large animal tumor models. We assessed the acute toxicity and biodistribution of 5 nm and 25 nm solid AuNPs in New Zealand White rabbits (n = 6 in each) with implanted liver Vx2 tumors 24 h after intravenous injection. Gold concentration was determined by inductively coupled plasma atomic emission spectrometry (ICP) and imaged with transmission electron microscopy (TEM). There was no clinico-pathologic evidence of renal, hepatic, pulmonary, or other organ dysfunction. After 25 nm AuNP administration, the concentration of white blood cells increased after treatment (p = 0.001). Most other blood studies were unchanged. AuNPs were distributed to the spleen, liver, and Vx2 tumors, but not to other tissues. The urinary excretion of AuNPs was bimodal as measured by ICP. 25 nm AuNPs were more evenly distributed throughout tissues and may be better tools for medical therapy.
Subject(s)
Gold/pharmacokinetics , Gold/toxicity , Liver Neoplasms, Experimental/metabolism , Metal Nanoparticles/toxicity , Animals , Blood Cell Count , Gold/administration & dosage , Gold/urine , Histocytochemistry , Injections, Intravenous , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/pathology , Mass Spectrometry , Metal Nanoparticles/administration & dosage , Microscopy, Electron, Transmission , Particle Size , Rabbits , Tissue DistributionABSTRACT
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide. In order to investigate the molecular biologic mechanism of HCC's development, we studied the expressions of SE-1, CD105 and CD31 in tumor endothelial cells (TECs) of HCC and in the serum of rats. METHODS: We analyzed the expressions of SE-1, CD31 and CD105 in rat HCC tumor tissues using immunohistochemistry (IHC). Twenty HCC bearing rats and eighteen normal rats were examined for the expressions of SE-1, CD31 and CD105 antigens in serum by enzyme-linked immunosorbent assay (ELISA). RESULTS: SE-1, CD31 and CD105 antigens were detected both in HCC tissue and in normal liver tissue with higher expressions of CD31 and CD105 in HCC while the SE-1 antigen expression was higher in normal liver. Similarly, serum CD31 and CD105 in rats with HCC were significantly increased compared with normal rats (t = 2.8628, P = 0.0086; t = 4.4922, P < 0.0001, respectively). In contrast, SE-1 antigen in HCC rat serum was significantly decreased compared with normal rats (t = 3.4983, P = 0.0011). CONCLUSION: SE-1, CD31 and CD105 are closely related with liver tumor angiogenesis, which is similar to their performances in terms of their expressions in the serum.
Subject(s)
Antigens, CD/blood , Carcinoma, Hepatocellular/chemistry , Endothelial Cells/chemistry , Liver Neoplasms, Experimental/chemistry , Platelet Endothelial Cell Adhesion Molecule-1/blood , Animals , Carcinoma, Hepatocellular/blood supply , Endothelial Cells/immunology , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Liver Neoplasms, Experimental/blood supply , Male , Neovascularization, Pathologic/blood , Rats , Rats, Inbred BUFABSTRACT
In contrast to extensive studies on tocopherols, very little is understood about tocotrienols (T3). We evaluated the antitumor activities of gamma-T3 and delta-T3 in murine hepatoma MH134 cells in vitro and in vivo. We found that delta-T3 inhibited the growth of MH134 cells more strongly than gamma-T3 by inducing apoptosis. In C3H/HeN mice implanted with MH134, it was found that gamma-T3 and delta-T3 feeding significantly delayed tumor growth. On the other hand, both T3 had no significant effect on body weight, normal-tissue weight and immunoglobulin levels. Intriguingly, we found that T3 was detected in tumor, but not in normal tissues. These results, to our knowledge, are the first demonstration of specific accumulation of gamma-T3 and delta-T3 in tumors and suggest that T3 accumulation is critical for the antitumor activities of T3.
Subject(s)
Antineoplastic Agents/pharmacology , Antioxidants/pharmacology , Cell Proliferation/drug effects , Chromans/pharmacology , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/pathology , Vitamin E/analogs & derivatives , Adipose Tissue/drug effects , Animals , Antibodies/blood , Antineoplastic Agents/adverse effects , Antineoplastic Agents/analysis , Antioxidants/administration & dosage , Apoptosis/drug effects , Body Weight/drug effects , Cell Line, Tumor , Chromans/administration & dosage , Chromans/analysis , Liver/chemistry , Liver Neoplasms, Experimental/chemistry , Lung/chemistry , Lymphocytes/chemistry , Male , Mice , Mice, Inbred C3H , Organ Size/drug effects , Spleen/cytology , Tumor Burden/drug effects , Vitamin E/administration & dosage , Vitamin E/analysis , Vitamin E/pharmacology , alpha-Tocopherol/analysisABSTRACT
AIM: To investigate the anti-tumor effect and mechanisms of magnetic nanoparticles targeting hepatocellular carcinoma. METHODS: Human hepatocellular carcinoma was induced in nude mice, and the mice were randomly divided into group A receiving normal saline, group B receiving magnetic nanoparticles containing 5-fluorouracil (5-FU), group C receiving 5-FU, and group D receiving magnetic nanoparticles containing 5-FU with a magnetic field built in tumor tissues. The tumor volume was measured on the day before treatment and 1, 4, 7, 10 and 13 d after treatment. Tumor tissues were isolated for examination of the expression of bcl-2, bax and caspase 3 by immunohistochemical method, reverse transcription polymerase chain reaction and Western blotting. RESULTS: The tumor volume was markedly lower in groups C and D than in groups A and B (group C or D vs group A or B, P<0.01). The volume was markedly lower in group D than in group C (P<0.05). The expression of protein and mRNA of bcl-2 was markedly lower in groups C and D than in groups A and B (group C or D vs group A or B, P<0.01), and was markedly lower in group D than in group C (P<0.01). The expression of bax and caspase 3 in groups C and D was significantly increased, compared with that in groups A and B (P<0.01). CONCLUSION: The targeted magnetic nanoparticles containing 5-FU can improve the chemotherapeutic effect of 5-FU against hepatocellular carcinoma by decreasing the expression of bcl-2 gene, and increasing the expression of bax and caspase 3 genes.
Subject(s)
Antineoplastic Agents/administration & dosage , Caspase 3/analysis , Fluorouracil/administration & dosage , Liver Neoplasms, Experimental/drug therapy , Magnetics , Nanoparticles , Proto-Oncogene Proteins c-bcl-2/analysis , bcl-2-Associated X Protein/analysis , Animals , Blotting, Western , Caspase 3/genetics , Humans , Liver Neoplasms, Experimental/chemistry , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Proto-Oncogene Proteins c-bcl-2/genetics , RNA, Messenger/analysis , bcl-2-Associated X Protein/geneticsABSTRACT
The albumin and alpha-fetoprotein genes are adjacent and express closely related serum proteins. Both genes are strongly expressed in fetal liver, primarily through activation by distant enhancers, but the AFP gene selectively undergoes developmental silencing. We used chromatin immunoprecipitation to study enhancers and promoters during active and silenced gene expression. In adult phenotype cells, the silenced AFP gene was actively repressed at the promoter and two proximal enhancers, characterized by the absence of coactivators and acetylated histone 4, and the presence of corepressors and K9-methylated histone 3. Specific transcription factors, TBP, and RNA polymerase II were all detected on both active and silenced genes, indicating that both states were actively regulated. Surprisingly, promoter-specific factors were also detected on enhancers, especially with reduced chromatin shearing. Under these conditions, an enhancer-specific factor was also detected on the albumin promoter. Association of promoter- and enhancer-specific factors was confirmed by sequential immunoprecipitation. Because no binding was detected on intervening segments, these promoter-enhancer associations suggest looping.
Subject(s)
Albumins/genetics , Enhancer Elements, Genetic , Gene Expression Regulation, Neoplastic/physiology , Gene Silencing/physiology , Promoter Regions, Genetic , alpha-Fetoproteins/genetics , Albumins/biosynthesis , Animals , Binding Sites/genetics , Chromatin/genetics , Genetic Markers , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/metabolism , Oligonucleotide Array Sequence Analysis , Rats , alpha-Fetoproteins/biosynthesisABSTRACT
Convective interaction media (CIM) monoliths provide a stationary phase with a high binding capacity for large molecules and are capable of high flow rates at a very low pressure drop. Used as anion- and cation-exchangers or with affinity ligands such as antibodies, these columns have the potential for processing large volumes of complex biological mixtures within a short time. In the present report, monoclonal antibodies against several rat liver plasma membrane proteins were bound and cross-linked to protein A or protein G CIM affinity columns with a bed volume of only 60 microL. Antigens recognized by bound antibodies and co-eluting (interacting) proteins were rapidly isolated in a single step from either total plasma membrane extracts or subfractions isolated using anion-exchange CIM disk-shaped columns. The isolated antigens and co-eluting proteins were subsequently identified by immunoblot or by LC-MS/MS.
Subject(s)
Cell Membrane/chemistry , Chromatography, Affinity/instrumentation , Membrane Proteins/isolation & purification , Animals , Antigens, CD/isolation & purification , Cell Adhesion Molecules/isolation & purification , Chromatography, Affinity/methods , Chromatography, Ion Exchange/methods , Chromatography, Liquid , Dipeptidyl Peptidase 4/isolation & purification , Liver/ultrastructure , Liver Neoplasms, Experimental/chemistry , Mass Spectrometry , Nerve Tissue Proteins/chemistry , Rats , Rats, Inbred F344 , Staphylococcal Protein A/chemistryABSTRACT
For proteomic analysis, plasma membranes of rat hepatocellular carcinoma Morris hepatoma 7777 were selectively solubilized according to the previously developed method [D. Josic, K. Zeilinger, Methods Enzymol. 271 (1996) 113-134]. If the Triton X100 insoluble pellet is subsequently extracted, several proteins can be solubilized. These proteins can be classified in two groups according to their molecular size. The proteins with apparent molecular weights in SDS-PAGE between 70 and 75 kDa belong to the first group. Smaller proteins, with apparent molecular weights between 30 and 45 kDa, are members of the second group. The main protein of higher molecular weight was also found in the Triton X100 insoluble extract from normal rat liver plasma membranes. This protein was identified as Annexin A6. The proteins from the second group are practically absent in the Triton X100 insoluble extract from rat liver. These proteins are present in relatively high concentrations in plasma membranes of Morris hepatoma 7777. Both groups of detergent-insoluble proteins from Morris hepatoma 7777 were further analyzed with SELDI-TOF and LC electrospray ionization mass spectrometry. From the first group, Annexin A6, together with two other integral plasma membrane proteins, was identified. In the second group of proteins with apparent molecular weights between 30 and 45kDa, further members of the annexin family, Annexins A1, A2, A4, A5 and A7 were identified. The possible role of these low molecular size annexins as potential cancer biomarkers is discussed.
Subject(s)
Annexins/isolation & purification , Cell Membrane/chemistry , Liver Neoplasms, Experimental/chemistry , Amino Acid Sequence , Animals , Biomarkers, Tumor/analysis , Calcium/pharmacology , Chromatography, Liquid , Egtazic Acid/pharmacology , Electrophoresis, Gel, Two-Dimensional , Electrophoresis, Polyacrylamide Gel , Molecular Sequence Data , Octoxynol , Rats , Solubility , Spectrometry, Mass, Electrospray Ionization/methodsABSTRACT
BACKGROUND & OBJECTIVE: Heat shock protein gp96 (HSPgp96) plays an important role in antigen presenting and specific antitumor immunotherapy, but its effects on macrophages need further investigation. This study was to investigate the effects of HSPgp96 derived from H22 tumor cells on mouse peritoneal elicited macrophages (PEMphi) by detecting some factors that are related to the function of the macrophages. METHODS: After macrophages were stimulated by HSPgp96, dynamic changes of intracellular free calcium (Ca2+), nitric oxide (NO) and reactive oxygen species (ROS) in the macrophages were measured by the laser scanning confocal microscopy (LSCM) with sensitive fluorescent dye Fluo-3/AM, DAF-FM-DA, and H2DCF-DA. The color immunofluorescence assay was used to observe the expression intensity and distribution of MHC II and CD86 in the macrophages. RESULTS: The production of Ca2+, NO and ROS increased rapidly in the macrophages after stimulation of HSPgp96. Their concentration peaks appeared at 30 s, 80 s, and 580 s after stimulation with the increase scopes of (161.06+/-70.99)%, (77.58+/-31.17)%, and (647.28+/-185.70)%, respectively. The positive rates of MHC II and CD86 were significantly higher in 60 mg/L HSPgp96-stimulated macrophages than in control macrophages [(61.8+/-5.1)% vs. (40.9+/-3.5)%, P<0.01; (54.9+/-2.0)% vs.(23.1+/-3.1)%, P<0.01]. CONCLUSION: The in vitro stimulation of HSPgp96 may enhance the production of Ca2+, NO and ROS in mouse PEMphi, and up-regulate the expression of MHC II and CD86.
Subject(s)
Antigens, Neoplasm/pharmacology , Genes, MHC Class II , Heat-Shock Proteins/pharmacology , Macrophages, Peritoneal/metabolism , Nitric Oxide/metabolism , Animals , Antigens, Neoplasm/isolation & purification , B7-2 Antigen/metabolism , Calcium/metabolism , Cell Line, Tumor , Female , Heat-Shock Proteins/isolation & purification , Histocompatibility Antigens Class II/metabolism , Liver Neoplasms, Experimental/chemistry , Liver Neoplasms, Experimental/pathology , Male , Mice , Mice, Inbred ICR , Reactive Oxygen Species/metabolismABSTRACT
Malignant growth is associated with various patterns of interaction between tumor cells and those of the body immune system, interaction between Fas-receptor (Fas) and Fas-ligand (FasL) expression being one of them. These mechanisms were simulated in vitro using the main cell populations from murine hepatoma MH-22a, histiocytic sarcoma J-774 and their clonal lines obtained from cocultivation of tumor cells and syngenic splenocytes. Fas and FasL expression was identified by the RT-PCR method while apoptosis--by electrophoresis of low molecular DNA fractions and clonogenic survival.